+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Immunotherapy Market Outlook 2027

  • ID: 4702435
  • Report
  • Region: Global
  • 370 pages
  • Research Nester Pvt. Ltd
1 of 4

FEATURED COMPANIES

  • Advaxis Inc.
  • Amgen Inc.
  • AstraZeneca
  • Bayer
  • Bristol Myers Squibb
  • Eli Lily and Co.
  • MORE
The global Cancer Immunotherapy market reached USD 42,584.18 Million in 2017 by registering a CAGR of 7.5% across the globe. Moreover, the market is expected to garner USD 86,678.7 Million by the end of 2027.

The global demand for Cancer Immunotherapy is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about early diagnosis and advanced personalized medicine as a part of targeted therapy is key growth driver for global Cancer Immunotherapy market over the forecast period.

North America is slated to account for a share of 37.0% by 2027 in the Cancer Immunotherapy market. The growth in the region can be attributed to growing prevalence of various types of cancer. Increasing technological innovations in Cancer Immunotherapy is also expected to impel the growth of Cancer Immunotherapy market in the North America. U.S. is the prominent market driving the growth in the region.

Additionally, U.S. Cancer Immunotherapy market reached USD 13,392.7 Million in 2017 and is expected to reach USD 27,986.4 Million by the end of 2027, expanding at a CAGR of 7.7% over the forecast period i.e. 2018-2027. U.S. Cancer Immunotherapy market is expected to achieve Y-o-Y growth rate of 8.6% in 2027 as compared to previous year.

Europe market is expected to expand at CAGR of 7.8% during the forecast period i.e. 2018-2027. Europe Cancer Immunotherapy market is projected to reach to a valuation of USD 25,830.2 Million by the end of 2027 from USD 12,349.4 Million in 2017.

Global Cancer Immunotherapy market is segmented on the basis of technology into Cellular Immunotherapy, Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines & Cytokine Therapy. Among these segments, Monoclonal Antibodies segment (65.5% share in 2017) occupies the largest market of Cancer Immunotherapy across the globe. Further, global Monoclonal Antibodies segment is anticipated to reach USD 56,290.7 Million by the end of 2027 from USD 27,911.8 Million in 2017. Moreover, this segment is anticipated to flourish at a CAGR of 7.4% over the forecast period. In addition, Immune Checkpoint Inhibitors segment of Cancer Immunotherapy is expected to achieve Y-o-Y growth rate of 8.9% in 2027 as compared to previous year.

In addition this, global Cancer Immunotherapy market is also segmented by end-user. In end-user segment, the hospitals segment is estimated to capture the highest market share during the forecast period. This segment contributed around 65.3% market share of total Cancer Immunotherapy market in 2017. Further, this segment is projected to capture 64.2% market share by 2027. Further, hospitals segment is projected to achieve Y-o-Y growth rate of 8.1% in 2027 as compared to previous year.

Pfizer, Merck, Amgen and Roche are some of the prominent players of Cancer Immunotherapy market.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Advaxis Inc.
  • Amgen Inc.
  • AstraZeneca
  • Bayer
  • Bristol Myers Squibb
  • Eli Lily and Co.
  • MORE

1. Research Methodology

2. Market Definitions, Assumptions & Abbreviations

3. Market Taxonomy

4. Global Cancer Immunotherapy Market - Executive Summary
4.1. Market Extracts by Technology
4.2. Market Extracts by End User
4.3. Market Extracts by Region

5. Cancer Immunotherapy Product Overview
5.1. Product Timeline
5.2. Features, by Product
5.3. Pipeline Products

6. Top Countries with Highest Demand for Cancer Immunotherapy, 2017

7. Recent Changes and Development in Cancer Immunotherapy Market by Geography
7.1. New Product Development
7.2. Merger and Acquisition
7.3. Expansion and others

8. Regional Average Pricing Analysis, 2017

9. Cancer Immunotherapy Value Chain Analysis

10. Supply Chain Analysis
10.1. Global Trade Agreement and Regulations, By Country
10.2. Global Trade Statistics (Exports and Imports), By Country

11. Porter’s Five Force Model Analysis

12. Cancer Immunotherapy Market - Risk Analysis
12.1. Demand Risk Analysis
12.2. Supply Risk Analysis

13. Market Dynamics & Its Impact Analysis
13.1. Growth Drivers
13.2. Challenges
13.3. Trends
13.4. Opportunities

14. Global Cancer Immunotherapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027

15. Global Cancer Immunotherapy Market Segmentation Analysis By Technology
15.1. Introduction
15.2. Cellular Immunotherapy
15.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.2.1.1. Market Value Increment Per Year, 2018-2027
15.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3. Monoclonal Antibodies
15.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3.1.1. Market Value Increment Per Year, 2018-2027
15.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.4. Immune Checkpoint Inhibitors
15.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.4.1.1. Market Value Increment Per Year, 2018-2027
15.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.5. Cancer Vaccines
15.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.5.1.1. Market Value Increment Per Year, 2018-2027
15.6. Cytokine Therapy
15.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.6.1.1. Market Value Increment Per Year, 2018-2027
15.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
15.7. Market Attractiveness Analysis By Technology
15.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology

16. Global Cancer Immunotherapy Market Segmentation Analysis By End User
16.1. Introduction
16.2. Hospitals
16.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
16.2.1.1. Market Value Increment Per Year, 2018-2027
16.3. Ambulatory Surgical Centers (ASCs)
16.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
16.3.1.1. Market Value Increment Per Year, 2018-2027
16.4. Clinics
16.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
16.4.1.1. Market Value Increment Per Year, 2018-2027
16.5. Others
16.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
16.5.1.1. Market Value Increment Per Year, 2018-2027
16.6. Market Attractiveness Analysis By End User
16.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User

17. Global Cancer Immunotherapy Market Segmentation Analysis By Geography
17.1. North America
17.1.1. Macro-economic Indicators Impacting the Growth of North America Cancer Immunotherapy Market
17.1.2. By Country
17.1.2.1. The U.S. & Canada
17.1.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.2.1.1.1. Market Value Increment Per Year, 2018-2027
17.1.2.2. Market Attractiveness Analysis By Country
17.1.2.3. Market Contribution and BPS Analysis, 2017 & 2027 By Country
17.1.3. By Technology
17.1.3.1. Introduction
17.1.3.2. Cellular Immunotherapy
17.1.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.2.1.1. Market Value Increment Per Year, 2018-2027
17.1.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3. Monoclonal Antibodies
17.1.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3.1.1. Market Value Increment Per Year, 2018-2027
17.1.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.4. Immune Checkpoint Inhibitors
17.1.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.4.1.1. Market Value Increment Per Year, 2018-2027
17.1.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.5. Cancer Vaccines
17.1.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.5.1.1. Market Value Increment Per Year, 2018-2027
17.1.3.6. Cytokine Therapy
17.1.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.6.1.1. Market Value Increment Per Year, 2018-2027
17.1.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.3.7. Market Attractiveness Analysis By Technology
17.1.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
17.1.4. By End User
17.1.4.1. Introduction
17.1.4.2. Hospitals
17.1.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.4.2.1.1. Market Value Increment Per Year, 2018-2027
17.1.4.3. Ambulatory Surgical Centers (ASCs)
17.1.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.4.3.1.1. Market Value Increment Per Year, 2018-2027
17.1.4.4. Clinics
17.1.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.1.4.5. Others
17.1.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.1.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.1.4.6. Market Attractiveness Analysis By End User
17.1.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
17.2. Latin America
17.2.1. Macro-economic Indicators Impacting the Growth of Latin America Cancer Immunotherapy Market
17.2.2. By Country
17.2.2.1. Brazil, Mexico & rest of LATAM
17.2.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.2.1.1.1. Market Value Increment Per Year, 2017-2027
17.2.2.2. Market Attractiveness Analysis By Country
17.2.2.3. Market Contribution and BPS Analysis, 2017 & 2027 By Country
17.2.3. By Technology
17.2.3.1. Introduction
17.2.3.2. Cellular Immunotherapy
17.2.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.2.1.1. Market Value Increment Per Year, 2018-2027
17.2.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3. Monoclonal Antibodies
17.2.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3.1.1. Market Value Increment Per Year, 2018-2027
17.2.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.4. Immune Checkpoint Inhibitors
17.2.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.4.1.1. Market Value Increment Per Year, 2018-2027
17.2.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.5. Cancer Vaccines
17.2.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.5.1.1. Market Value Increment Per Year, 2018-2027
17.2.3.6. Cytokine Therapy
17.2.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.6.1.1. Market Value Increment Per Year, 2018-2027
17.2.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.3.7. Market Attractiveness Analysis By Technology
17.2.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
17.2.4. By End User
17.2.4.1. Introduction
17.2.4.2. Hospitals
17.2.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.2.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.3. Ambulatory Surgical Centers (ASCs)
17.2.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.3.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.4. Clinics
17.2.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.5. Others
17.2.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.6. Market Attractiveness Analysis By End User
17.2.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
17.3. Europe
17.3.1. Macro-economic Indicators Impacting the Growth of Europe Cancer Immunotherapy Market
17.3.2. By Country
17.3.2.1. U.K., Germany & France
17.2.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.5. Others
17.2.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.2.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.2.4.6. Market Attractiveness Analysis By End User
17.2.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
17.3. Europe
17.3.1. Macro-economic Indicators Impacting the Growth of Europe Cancer Immunotherapy Market
17.3.2. By Country
17.3.2.1. U.K., Germany & France
17.3.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.2.1.1.1. Market Value Increment Per Year, 2017-2027
17.3.2.2. Italy, Spain & Russia
17.3.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.2.2.1.1. Market Value Increment Per Year, 2017-2027
17.3.2.3. Poland & Turkey
17.3.2.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.2.3.1.1. Market Value Increment Per Year, 2017-2027
17.3.2.4. BENELUX & Rest of Europe
17.3.2.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.2.4.1.1. Market Value Increment Per Year, 2017-2027
17.3.2.5. Market Attractiveness Analysis By Country
17.3.2.6. Market Contribution and BPS Analysis, 2017 & 2027 By Country
17.3.3. By Technology
17.3.3.1. Introduction
17.3.3.2. Cellular Immunotherapy
17.3.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.2.1.1. Market Value Increment Per Year, 2018-2027
17.3.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3. Monoclonal Antibodies
17.3.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3.1.1. Market Value Increment Per Year, 2018-2027
17.3.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.4. Immune Checkpoint Inhibitors
17.3.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.4.1.1. Market Value Increment Per Year, 2018-2027
17.3.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.5. Cancer Vaccines
17.3.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.5.1.1. Market Value Increment Per Year, 2018-2027
17.3.3.6. Cytokine Therapy
17.3.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.6.1.1. Market Value Increment Per Year, 2018-2027
17.3.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.3.7. Market Attractiveness Analysis By Technology
17.3.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
17.3.4. By End User
17.3.4.1. Introduction
17.3.4.2. Hospitals
17.3.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.4.2.1.1. Market Value Increment Per Year, 2018-2027
17.3.4.3. Ambulatory Surgical Centers (ASCs)
17.3.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.4.3.1.1. Market Value Increment Per Year, 2018-2027
17.3.4.4. Clinics
17.3.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.3.4.5. Others
17.3.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.3.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.3.4.6. Market Attractiveness Analysis By End User
17.3.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
17.4. Asia Pacific
17.4.1. Macro-economic Indicators Impacting the Growth of Asia Pacific Cancer Immunotherapy Market
17.4.2. By Country
17.4.2.1. India, China & Japan
17.4.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.2.1.1.1. Market Value Increment Per Year, 2017-2027
17.4.2.2. Australia, New Zealand & South Korea
17.4.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.2.2.1.1. Market Value Increment Per Year, 2017-2027
17.4.2.3. Malaysia, Singapore & rest of Asia Pacific
17.4.2.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.2.3.1.1. Market Value Increment Per Year, 2017-2027
17.4.2.4. Market Attractiveness Analysis By Country
17.4.2.5. Market Contribution and BPS Analysis, 2017 & 2027 By Country
17.4.3. By Technology
17.4.3.1. Introduction
17.4.3.2. Cellular Immunotherapy
17.4.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.2.1.1. Market Value Increment Per Year, 2018-2027
17.4.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3. Monoclonal Antibodies
17.4.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3.1.1. Market Value Increment Per Year, 2018-2027
17.4.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.4. Immune Checkpoint Inhibitors
17.4.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.4.1.1. Market Value Increment Per Year, 2018-2027
17.4.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.5. Cancer Vaccines
17.4.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.5.1.1. Market Value Increment Per Year, 2018-2027
17.4.3.6. Cytokine Therapy
17.4.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.6.1.1. Market Value Increment Per Year, 2018-2027
17.4.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.3.7. Market Attractiveness Analysis By Technology
17.4.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
17.4.4. By End User
17.4.4.1. Introduction
17.4.4.2. Hospitals
17.4.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.4.2.1.1. Market Value Increment Per Year, 2018-2027
17.4.4.3. Ambulatory Surgical Centers (ASCs)
17.4.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.4.3.1.1. Market Value Increment Per Year, 2018-2027
17.4.4.4. Clinics
17.4.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.4.4.5. Others
17.4.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.4.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.4.4.6. Market Attractiveness Analysis By End User
17.4.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
17.5. Middle East & Africa
17.5.1. Macro-economic Indicators Impacting the Growth of Middle East & Africa Cancer Immunotherapy Market
17.5.2. By Country
17.5.2.1. GCC, Israel & North Africa
17.5.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.2.1.1.1. Market Value Increment Per Year, 2017-2027
17.5.2.2. South Africa & Rest of Middle East & Africa
17.5.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.2.2.1.1. Market Value Increment Per Year, 2017-2027
17.5.2.3. Market Attractiveness Analysis By Country
17.5.2.4. Market Contribution and BPS Analysis, 2017 & 2027 By Country
17.5.3. Middle East & Africa Cancer Immunotherapy Market Segmentation Analysis By Technology
17.5.3.1. Introduction
17.5.3.2. Cellular Immunotherapy
17.5.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.2.1.1. Market Value Increment Per Year, 2018-2027
17.5.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3. Monoclonal Antibodies
17.5.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3.1.1. Market Value Increment Per Year, 2018-2027
17.5.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.4. Immune Checkpoint Inhibitors
17.5.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.4.1.1. Market Value Increment Per Year, 2018-2027
17.5.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.5. Cancer Vaccines
17.5.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.5.1.1. Market Value Increment Per Year, 2018-2027
17.5.3.6. Cytokine Therapy
17.5.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.6.1.1. Market Value Increment Per Year, 2018-2027
17.5.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.3.7. Market Attractiveness Analysis By Technology
17.5.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
17.5.4. Middle East & Africa Cancer Immunotherapy Market Segmentation Analysis By End User
17.5.4.1. Introduction
17.5.4.2. Hospitals
17.5.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.4.2.1.1. Market Value Increment Per Year, 2018-2027
17.5.4.3. Ambulatory Surgical Centers (ASCs)
17.5.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.4.3.1.1. Market Value Increment Per Year, 2018-2027
17.5.4.4. Clinics
17.5.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.4.4.1.1. Market Value Increment Per Year, 2018-2027
17.5.4.5. Others
17.5.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
17.5.4.5.1.1. Market Value Increment Per Year, 2018-2027
17.5.4.6. Market Attractiveness Analysis By End User
17.5.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User

18. Competitive Landscape
18.1. Competitive Positioning of Major Players in Global Cancer Immunotherapy Market
18.2. Company Profiles
18.2.1. AstraZeneca
18.2.1.1. Company Overview
18.2.1.2. Business Strategy
18.2.1.3. Key Product Offerings
18.2.1.4. Financial Performance
18.2.1.5. Key Performance Indicators
18.2.1.6. Risk Analysis
18.2.1.7. Recent Development
18.2.1.8. Regional Presence
18.2.1.9. SWOT Analysis
18.2.2. Merck & Co.
18.2.3. Novartis
18.2.4. Advaxis Inc
18.2.5. Bristol-Myers Squibb (BMS)
18.2.6. Bayer AG
18.2.7. Roche
18.2.8. Eli Lilly and Co.
18.2.9. Amgen Inc
18.2.10. Pfizer Inc

19. Guide to the Industry by Region & Analyst’s Recommendations

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca
  • Merck
  • Novartis
  • Advaxis Inc.
  • Bristol Myers Squibb
  • Bayer
  • Roche
  • Eli Lily and Co.
  • Amgen Inc.
  • Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll